NCT00300924View on ClinicalTrials.gov

A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Migraine
Interventions
DRUG

Rizatriptan co-administered with Acetaminophen

Trial Locations (7)

10550

Elkind Headache Center, Mount Vernon

44121

ClinExcel, West Chester

49009

Westside Family Medical Center, Kalamazoo

60614

Diamond Headache Clinic, Chicago

63141

Mercy Health Research, St Louis

94109

SanFrancisco Headache Clinic, San Francisco

Unknown

Clinvest, Springfield

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Diamond Headache Clinic

OTHER

NCT00300924 - A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine | Biotech Hunter | Biotech Hunter